Detalhe da pesquisa
1.
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
Oncologist
; 27(4): 255-265, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274704
2.
Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report.
BMC Pulm Med
; 20(1): 71, 2020 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199453
3.
A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer.
Oncology
; 94(6): 373-382, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29502124
4.
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer.
J Korean Med Sci
; 33(53): e342, 2018 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30595683
5.
Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report.
J Korean Med Sci
; 33(1): e7, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29215816
6.
Caveolin-1 regulates osteoclastogenesis and bone metabolism in a sex-dependent manner.
J Biol Chem
; 290(10): 6522-30, 2015 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25561739
7.
Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.
BMC Cancer
; 16: 690, 2016 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566413
8.
Predictors of Default from Treatment for Tuberculosis: a Single Center Case-Control Study in Korea.
J Korean Med Sci
; 31(2): 254-60, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26839480
9.
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.
J Korean Med Sci
; 31(12): 1914-1921, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27822929
10.
Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers.
J Obes Metab Syndr
; 33(1): 36-44, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246603
11.
Immune checkpoint inhibitor score (IChIS) predicts survival benefit of immunotherapy in patients with non-small cell lung cancer.
Tuberc Respir Dis (Seoul)
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749491
12.
Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial.
Clin Cancer Res
; 30(8): 1478-1487, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593249
13.
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Thorac Cancer
; 15(6): 448-457, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171544
14.
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study.
Thorac Cancer
; 14(27): 2777-2784, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567781
15.
Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study).
Cancers (Basel)
; 15(23)2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067272
16.
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.
Cancers (Basel)
; 15(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831494
17.
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer.
Cancers (Basel)
; 15(5)2023 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900397
18.
Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial.
Int J Radiat Oncol Biol Phys
; 115(4): 873-885, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280151
19.
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial.
Cells
; 12(9)2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174645
20.
Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer.
Sci Rep
; 13(1): 18126, 2023 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872370